Researchers in the Department of Chemistry and the Department of Molecular Biology have used a cellular mapping technology called µMap, introduced just two years ago by the MacMillan Lab, to uncover eight novel entry factors of interest for the spike protein.
The new approach, developed by researchers including Cameron Myhrvold, draws on principles of gene editing and could improve the speed and specificity of SARS-COV-2 testing both at home and in the clinic. The advance was reported on May 30, 2022 in the journal Nature Biomedical Engineering.
